Pharmacogenetics (Nerissa Dando, MD) Flashcards

1
Q

What is the goal for non-responders? Toxic responders?

A

Drug efficacy; drug safety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the three possible effects of drug administration?

A

Therapeutic effect
Adverse effect
Lethal effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe: Succinylcholine

A
Anesthetic agent (muscle relaxant)
ADR: overparalysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What type of drug is primaquine?

A

Antimalarial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What type of drug is isoniazid (INH)?

A

Anti-tuberculosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Intake of primaquine causes ADRs among African-Americans where they develop (1) which leads to (2).

A

(1) G6PD deficiency

(2) hemolytic anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Who developed the concept of chemical sensitivity?

A

Archibald Garrod

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Define: Alcaptonuria

A

Excretion of homogenateisic acid in urine due to congenital absence of homogentisate 1,2 dioxygenase.

No breakdown of phenylalanine and tyrosine.

Urine is dark.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Enumerate Mendel’s Four Principles of Inheritance

A
  1. Genes come in pairs.
  2. Dominance and recessiveness
  3. Principle of segregation
  4. Principle of independent assortment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How many possible codons are there?

A

64

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the sequence of the start codon? Stop codons?

A

Start codon - AUG

Stop codons - UAA, UAG, UGA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Enumerate the basic patterns of inheritance

A

Autosomal Dominant
Autosomal Recessive
X-linked
Mitochondrial Inheritance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Give examples of X-linked diseases

A

G6PD deficiency
Pyridoxine sensitive anemia
Vasopressin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

T/F: Mitochondrial inheritance is secondary to exposure to aminoglycosides like streptomycin, gentamycin and amikacin.

A

True

i.e. aminoglycoside-induced deafness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the factors affecting drug sensitivity?

A

Genetics
Disease
Age
Drug related factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which groups of patients are most sensitive to the effects of drugs?

A

Geriatric
Preterm
Chronically Ill

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What drug related factors affect drug sensitivity?

A

Pharmaceutical formulation
Route of administration
Drug interaction
Environmental factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Enumerate extrinsic factors affecting drug sensitivity

A

Drug-food interaction (grapefruit juice, alcohol & histamine cause sedation)
Environmental chemicals
Vices

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Enumerate intrinsic factors affecting drug sensitivity

A

Physiological and pathophysiological attributes of a person (age, gender, weight, etc.)
Patient characteristics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Define: Gene

A

Unit of heredity on a chromosome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Define: Alleles

A

Alternative forms of genes that occur in pairs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

It includes all alleles present in the cell whether dominant or recessive, expressed or not.

A

Genotype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Physical manifestation of a trait

A

Phenotype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What method can predict whether an individual is a candidate for polymerphic metabolism?

A

Molecular Genotyping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What methods are commonly employed in molecular genotyping?

A

Polymerase chain reaction (PCR)

Restriction fragment length polymorphism mapping (RFLM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Method accomplished by administering a probe to an individual followed by analysis of metabolites in blood or urine

A

Phenotyping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What anti-hypertensive drug is used to identify the activity of CYP450?

A

Drebisoquine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Enumerate the three potential applications of molecular genotyping in drug development

A
  1. Determine safety and efficacy of investigational new drug prior to approval
  2. Protect patients against ADRs by identifying poor metabolisers
  3. Establish an individual’s genetic predisposition to disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Define: Monogenic

A

Due to allelic variation at a single gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Define: Polygenic

A

Due to variations at two or more genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What describes frequently occurring monogenic variants occurring at a frequency > 1%?

A

Polymorphic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What are the most common polymorphisms?

A

Single nucleotide polymorphisms (SNPs)

Copy number variations (CNVs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What are less common polymorphisms?

A

Insertions

Deletions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What are the two types of gross rearrangements?

A

Inversions

Translocations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

These are implicated in human diseases (i.e. cancer and Alzheimer’s) but most have no known clinical effects.

A

Single Nucleotide Polymorphisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What are the different types of SNPs?

A

Missense
Nonsense
Frameshift by addition
Frameshift by deletion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

How many SNPs have been identified in the human genome?

A

2 million

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

T/F: A polymorphic distribution follows a normal distribution.

A

False

70 - 90% of them are found in extremes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Enumerate the project goals of the Human Genome Project

A
  1. Identify all 30,000 genes in human DNA
  2. Determine sequences of 3 billion base pairs
  3. Store the information
  4. Improve tools for data analysis
  5. Transfer technologies to private sector
  6. Address ELSI (ethical, legal and social issues) that may arise
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

When was a working draft of the human genome completed?

A

June 2000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

When were analysis of the working draft published?

A

February 2001

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

T/F: To be important, SNPs must affect either function or amount of a protein.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

What are the possible effects of genetic polymorphisms?

A
  1. Pharmacokinetic (enzymes, transporters and binding proteins)
  2. Pharmacodynamic (target proteins, receptors and ion channels)
  3. Idiosyncratic Responses (no explanation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Refers to genetic loci in which variants occur with a frequency of 1 - 2%

A

Genetic Polymorphism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Twin and family studies enable discrimination of?

A

Various modes of genetic transmission

Dominance-recessivity relationships

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

T/F: Pharmacogenomics is a subset of pharmacogenetics.

A

False

It’s the other way around.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Define: Pharmacogenomics

A

Study of variations of DNA AND RNA characteristics related to drug response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Define: Pharmacogenetics

A

Study of genetically controlled variations in DNA sequence related to drug response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

According to pharmacogenomics, what is the key to creating personalised drugs with greater efficacy and safety?

A

Understanding an individual’s genetic make-up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Define: Poor Metabolizers

A

Slower-than-usual metabolism leading to toxicity

May be due to liver or kidney failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Define: Ultra-rapid Metabolizers

A

Observed therapeutic failure

Variability in drug target genes

52
Q

T/F: There is poor efficacy of prodrugs in slow metabolizers and ADR risk in ultra-rapid metabolizers.

A

True

53
Q

Give examples of prodrugs.

A

Codeine
Tamoxifen
Clopidogrel

54
Q

What is seen in CYP2D6 poor metabolises of debrisoquine?

A

Marked hypotension

Note: This is not an ADR.

55
Q

What group has the largest incidence of G6PD deficiency?

A

Indians-Parsees

56
Q

T/F: Newborn screening cannot detect G6PD deficiency.

A

False

57
Q

Enumerate the drugs demonstrated to precipitate haemolytic anemia in G6PD deficients

A
Acetanilide
Methylene blue
Nalidixic acid
Naphthalene
Sulfapyridine
Sulfanilamide
Sulfamethixazole
Primaquine
Sulfacetamide
Nitrofurantoin
Nitrates
58
Q

Example of an unusual drug response is malignant hyperthermia following the use of what?

A

Halothane (anaesthetic agent)

59
Q

What is the classic presentation of malignant hyperthermia?

A
Rapid rise in body temperature
Muscle rigidity
Tachycardia
Rhabdomyolysis
Severe acidosis
Hyperkalemia
60
Q

What is the antidote for malignant hyperthermia?

A

L.V. dantrolene

61
Q

What causes malignant hyperthermia?

A

Mutations in the ryanodine receptor

62
Q

In cases of Warfarin resistance, by how much does the dose need to be increased?

A

7 - 20 times recommended therapeutic dose

63
Q

In cases of folate resistance, by how much does the dose need to be increased?

A

40 - 1000 times daily recommended dose

64
Q

T/F: Fast acetylators are susceptible to phenytoin toxicity when phenytoin and isoniazid are given together.

A

False

Slow acetylators!

65
Q

T/F: Individualizing therapy is important for drugs with a wide therapeutic range.

A

False

Narrow!

66
Q

Increased risk of cancer is associated with polymorphisms in what genes?

A

CYP (2A1, 1A2 and 2E1)
Glutathione transferases (GSMT1, GSTT1)
Epoxide hydrolase
NAT2 - N-acetyl transferase 2

67
Q

T/F: Drug clearance typically removes drugs via enzymatic transformation into more hydrophobic metabolites.

A

False

Hydrophilic!

68
Q

T/F: Cytochrome P450 enzymes are responsible for Phase II oxidative metabolism of steroid hormones, xenobiotics and carcinogens.

A

False

Phase I oxidative metabolism!

69
Q

What CYPs are important for Phase I?

A

CYP3A4, CYP2C19 and CYP2D6

70
Q

What enzymes are important for Phase II?

A

TPMT, NAT1 & NAT2

71
Q

What are the mechanisms of variation in drug response?

A
  1. Modification of absorption of xenobiotic
  2. Modified metabolism resulting in modification of rate, pattern of elimination, detoxification or activation of a given xenobiotic
  3. Modification in the abundance, affinity or function of a target enzyme or receptor
72
Q

What factors influence absorption of the xenobiotic?

A
  1. Rapid metabolizer
  2. Decreased abundance of transport protein
  3. Enhanced excretion by multi-drug resistance protein
73
Q

T/F: When the main metabolic pathway leading to a harmless metabolite is blocked, parent drug could accumulate and cause toxicity.

A

True

74
Q

T/F: Deficiency of methemoglobin reductase is inherited as an autosomal recessive trait.

A

True

75
Q

T/F: Methemoglobin reductase homozygotes are predisposed to develop methemoglobinemia when exposed to nitrates and other stress.

A

False

Heterozygotes!

76
Q

Give an example of a modification in the abundance, affinity or function of a target enzyme or receptor.

A
  1. Silent variants of serum cholinesterase associated with succinylcholine
  2. Poor metaboliser variants of CYP2D6 and CYP2C19
77
Q

Describe the metabolism of ethanol by the body

A

Ethanol -> acetaldehyde (by ADH) -> acetate (by ALDH)

78
Q

T/F: The rate of ethanol metabolism of genetically controlled.

A

True

79
Q

T/F: Atypical ADH exhibits higher catalytic activity and typically contains a variant alpha 2 subunit.

A

False

Variant beta 2 subunit!

80
Q

What ethnic group has the largest distribution of atypical ADH?

A

Swiss (20%)

81
Q

How does the atypical B2 subunit of alcohol dehydrogenase differ from the typical?

A

CGC to CAC transition resulting in an Arg47His substutition

82
Q

What does the atypical ADH subunit mutation cause?

A

Higher ethanol Vmax

Higher Km for the homozygous B2B2

83
Q

What are the three genotypes for aldehyde dehydrogenase?

A
  1. Homozygote normal
  2. Heterozygote
  3. Deficient homozygote
84
Q

What causes the “flush” and feelings of discomfort associated with ethanol intake?

A

Acetaldehyde accumulation

85
Q

Describe: cyclophosphamide polymorphic biotransformation

A

Antineoplastic agents that cause cystitis

86
Q

Familial pyrimidinemia and pyridinuria are associated with what?

A

5-fluorouracil induced toxicity

87
Q

Major toxic manifestation of 5FU in DPD occurs in what tissue?

A

Bone marrow

88
Q

What are the two phenotypes for mephenytoin hydroxylation polymorphism?

A
  1. Poor metaboliser

2. Extensive metabolizer

89
Q

Mephenytoin hydroxylation is mediated by what enzyme?

A

CYP2C19

90
Q

What are the types of parathion poisoning and paraoxon polymorphism?

A

PON1 & PON2

91
Q

What causes the hydrolysis of succinylcholine?

A

Pseudocholinesterase

92
Q

How do you document pseudocholinesterase deficiency?

A

History taking

Unexpected persistent respiratory paralysis for a prolonged period of time

93
Q

Enumerate a few examples of choline ester compounds

A

Succinylcholine
Mivacarium
Cocaine

94
Q

Atypical plasma cholinesterase causes (1) that lasts (2)

A

(1) paralysis
(2) 2 - 6 mins

Note: Patients deficient in the enzyme experience 1-hour long paralysis episodes.

95
Q

How many % of succinylcholine is inactivated by normal functioning pseudocholinesterase?

A

90 - 95%

96
Q

T/F: Flaccid paralysis of skeletal muscle develops within 1 minute of succinylcholine binding

A

True

97
Q

What is the cause of pseudocholinesterase deficiency?

A

Abnormal alleles that code for the enzyme

98
Q

Where is the gene coding for pseudocholinesterase located?

A

E1 locus on the long arm of chromosome 3

99
Q

How many % of the population carries one or more of the atypical gene alleles for pseudocholinesterase gene?

A

4%

100
Q

How is the dibucaine-resistant genetic variant form of pseudocholinesterase detected?

A

Percent inhibition of hydrolysis of benzyl choline caused by addition of dibucaine (dibucaine number)

101
Q

What is the DN value for normal homozygotes? for the atypical dibucaine resistant genotype?

A

80%; 20%

102
Q

How is the fluoride-resistant pseudocholinesterase enzyme variant detected?

A

Percent inhibition of benzyl choline hydrolysis when fluoride is added to assay

103
Q

What is the FN value for normal homozygotes? for the atypical homozygotes?

A

60%; 36%

104
Q

What is the most severe form of atypical pseudocholinesterase?

A

Silent form

105
Q

T/F: Only 1 in 100,000 individuals are homozygous for the silent Es genotype with no detectable pseudocholinesterase enzyme activity.

A

True

106
Q

What causes the silent Es genotypes?

A

Gene mutations by frameshift or stop codon

107
Q

What is the cause of fish odor syndrome?

A

Excessive excretion of trimethylaminuria (TMA) in urine, sweat and breath

108
Q

What is the prodrug used to check the activity of CYP2D6?

A

Debrisoquine

109
Q

T/F: If you give a patient debrisoquine and there is marked hypotension, the phenotypic presentation is ultra rapid metabolism.

A

False

Poor metabolism!

110
Q

What are drugs that can cause increased toxicity in ultra rapid metabolizers?

A

Codeine-narcotic and opioid

111
Q

What are drugs with an extremely narrow therapeutic index?

A

Antiarrythmitics
Antidepressants
Antipsychotics

112
Q

What are the two N-acetyltransferase isozymes?

A

NAT1 and NAT2

113
Q

T/F: Filipinos are fast acetylators.

A

True

114
Q

NAT2 allele polymorphism produces what phenotypes?

A

Rapid acetylator
Intermediate acetylator
Slow acetylator

115
Q

T/F: Due to NAT2 polymorphism, there is a higher incidence and/or severity of adverse drug reactions to isoniazid, hydrazine, procainamide and sulfamethaxazole.

A

True

116
Q

NAT2 activates and deactivates many of the (1) and (2) amine carcinogens.

A

(1) Aromatic

(2) Heterocyclic

117
Q

T/F: There is no association between acetylation polymorphism and urinary bladder & colorectal cancers.

A

False

There is!

118
Q

Slow acetylators have an 8-fold higher risk of what compared to fast acetylators?

A

Cancer

119
Q

Rapid acetylators are at increased risk of what from acetylation of heterocyclic amines found in cooked meats?

A

Colon cancer

120
Q

Where has human NAT2 been localised?

A

Short arm of chromosome 8

121
Q

What allele is associated with rapid acetylators?

A

NAT2*4

122
Q

What alleles are associated with poor acetylators?

A

NAT25B, NAT26A and NAT2*14A

123
Q

What complications does thiopurinemethyltransferase (TPMT) polymorphism cause?

A

Severe coma or depression after giving certain anti-cancer drugs

In AFL, patients may develop myosuppression

124
Q

Patients with TPMT polymorphism will experience toxicity after administration of what?

A

6-mercaptopurine

125
Q

T/F: TPMT is found in patients with acute lymphoblastic leukaemia.

A

True

126
Q

With pharmacogenetics, we aim for (1) and (2).

A

(1) efficacy

(2) safety